FDA PROPOSAL FOR U.S./EUROPEAN MRA MAY INCORPORATE AGENCY THIRD-PARTY DEVICE REVIEW PILOT; AIM WOULD BE TO BREAK STALEMATE OVER PRODUCT APPROVALS
This article was originally published in The Gray Sheet
Executive Summary
A U.S.-European Union device mutual recognition agreement proposal under development by FDA may incorporate the agency's third-party review pilot as a means for including product approvals in the pact.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.